two new investigational drugs for diabetes

You'll hear about two new investigational drugs for diabetes... Pargluva (muraglitazar) and Exubera (inhaled insulin).

Both are being considered for approval this month.

Pargluva is the first in a new class...called glitazars.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote